Catinazzo Thomas sold $27K of RLAY
Catinazzo Thomas (Chief Financial Officer) sold 1,459 shares of Relay Therapeutics, Inc. (RLAY) at $18.61 on 2026-07-28.
How this was made
The 30-second read
Why it matters
The only new fact is the CFO’s open-market sale size, price, and post-transaction holdings; it does not include any accompanying company guidance or event.
Market read
Traders may note the insider sale for sentiment, but there is no fundamental catalyst in the text.
What to watch
The article lacks context on total holdings, prior sale history, and whether proceeds relate to taxes or diversification, limiting inference.
Background
The article is an SEC Form 4 insider transaction disclosure for Relay Therapeutics, Inc.
Ticker impact
Relay Therapeutics CFO Thomas Catinazzo sold 1,459 shares at $18.61 in an SEC Form 4 open-market sale.
Low likelihood of a sustained price move; any reaction is likely muted unless paired with other new company catalysts.
The filing is a Form 4 insider transaction, and the article provides no new operational, financial, or regulatory development beyond the sale details.
Market effects
No clear sector read-through from a single CFO open-market sale.
None indicated.
None indicated.
Counterpoint
Insider sales are often planned for diversification or tax needs, and the absence of a 10b5-1 plan does not necessarily imply negative fundamentals.
Key entities
- issuerRelay Therapeutics, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderThomas Catinazzo
Chief Financial Officer who reported the sale.
